CHEMOTHERAPY
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
CHEMOTHERAPY
CHEMOTHERAPY
ISSN / eISSN
0009-3157 / 1421-9794
Aims and Scope
This journal publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamics properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide.
Subject Area
ONCOLOGY
PHARMACOLOGY & PHARMACY
CiteScore
5.70
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Medicine - Pharmacology (medical) | Q2 | #72/260 |
| Medicine - Infectious Diseases | Q2 | #100/304 |
| Medicine - Oncology | Q2 | #135/366 |
| Medicine - Pharmacology | Q2 | #119/301 |
| Medicine - Drug Discovery | Q2 | #67/156 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| ONCOLOGY - SCIE | Q3 |
| PHARMACOLOGY & PHARMACY - SCIE | Q3 |
H-index
49
Country/Area of Publication
SWITZERLAND
Publisher
S. Karger AG
Publication Frequency
Bimonthly
Year Publication Started
1968
Annual Article Volume
38
Open Access
NO
Contact
KARGER, ALLSCHWILERSTRASSE 10, BASEL, SWITZERLAND, CH-4009
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started